New study aims to stop muscle loss during GLP-1 weight loss
NCT ID NCT07554417
First seen May 02, 2026 · Last updated May 20, 2026 · Updated 4 times
Summary
This study tests whether a 12-week program of exercise and personalized diet advice can help adults aged 40-55 prevent muscle loss while taking GLP-1 medications like semaglutide for weight loss. About 20 participants will be enrolled. The goal is to preserve muscle and bone health during treatment, improving long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE LOSS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Rice University
Houston, Texas, 77005, United States
Conditions
Explore the condition pages connected to this study.